May 2nd 2024
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
Dangerous Liaisons: Elder Abuse and Metabolic Syndromes
December 22nd 2014Around 10% of elders experience some form of elder abuse (physical, sexual or emotional abuse; neglect, exploitation, or abandonment), and elders who are abused appear to have a high level of comorbidity. Evidence suggests that patients who have experienced elder abuse are at higher risk of cardiovascular-related mortality.
Statins for Everyone: Maybe, Maybe Not
December 12th 2014The 2013 American College of Cardiology/American Heart Association guideline for management of low-density lipoprotein cholesterol to reduce atherosclerotic cardiovascular disease risk identified adults who could benefit from moderate- to high-intensity statin use.
Zigzag Calorie Cycling: A Novel Path to Weight Loss
December 3rd 2014Also known as alternate day fasting, "zigzag" caloric cycling calls for the dieter to eat the number of calories required to maintain weight one day, and then 25% of his or her energy needs on the fast day. Studies have shown that individuals who are compliant with this pattern can lose 4% to 8% of their body weight over 8 to 12 weeks.
The Burden of Disease in Homozygous Familial Hypercholesterolemia
November 4th 2014Homozygous familial hypercholesterolemia (HoFH) is a rare and severe hereditary lipid disorder. Patients with HoFH generally have very high serum levels of low-density lipoprotein cholesterol (LDL-C) that is treatment-resistant. HoFH puts affected patients at extremely high risk of premature onset coronary heart disease, and many patients die before they reach their mid-30s.
Can Prebiotics and Probiotics Really Improve Gastrointestinal Health?
June 3rd 2014Prebiotics and probiotics have been discussed frequently in the media for supposedly improving overall health, especially diseases related to the gut. However, the evidence on the efficacy and use of these dietary supplements is rather complicated.
Cardiovascular Risk Factors Associated with Psoriatic Arthritis Complicate Treatment Decisions
May 28th 2014Patients with psoriatic arthritis may be at increased risk for cardiovascular disease, so physicians must carefully weigh the pros and cons of treatment with corticosteroids and other proatherogenic drugs.
Do You Support the New Cholesterol Guidelines and Risk Calculator?
April 17th 2014In this edition of Clinical Forum, we asked Cardiology Review editorial board members and an invited guest to comment on the controversial new cholesterol guidelines and risk calculator issued by the American Heart Association (AHA) and American College of Cardiology (ACC) in November 2013.
More on the Controversies Surrounding Implementation of New Lipid Management Guidelines
April 13th 2014The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.
Heartache Over New Cholesterol Treatment Guidelines
April 2nd 2014To produce the greatest impact from the implementation of the new American College of Cardiology and American Heart Association guidelines for the treatment of hypercholesterolemia in the primary prevention of cardiovascular disease (CVD), physicians should counsel patients on the benefits and risks of medication intervention to prevent CVD, but also explain the absolute necessity of regular exercise and abstention from tobacco use.
STABILITY Trial Results: Novel Plaque Inhibitor Darapladib Fails to Show Cardiovascular Benefit
April 1st 2014Darapladib, a novel agent targeting an enzyme known to be associated with increased instability of atherosclerotic plaque, failed to show real-world benefit in a large global trial examining mortality and coronary outcomes.